Cinctive Capital Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-78,736
Closed -$2.48M 614
2022
Q2
$2.48M Buy
+78,736
New +$2.1M 0.1% 285
2021
Q3
Sell
-24,000
Closed -$796K 644
2021
Q2
$796K Buy
+24,000
New +$665K 0.04% 383

Other funds holding TMDX

Cinctive Capital Management's TMDX Position: Q3 2022 in Review

Cinctive Capital Management sold out of Transmedics (TMDX) in Q3 2022, closing a stake of 78,736 shares — an estimated $2.48M sold.

Cinctive Capital Management first reported a position in TMDX in Q2 2021 and held it in 2 quarters. The position peaked at $2.48M in Q2 2022. 178 funds tracked by Wall St. Rank hold TMDX as of Q3 2022.

  • Cinctive Capital Management reported no remaining Transmedics position as of Q3 2022 after selling out during the quarter.
  • Cinctive Capital Management sold 78,736 Transmedics shares in Q3 2022, an estimated $2.48M.
  • Cinctive Capital Management first reported a position in Transmedics in Q2 2021 and held it in 2 quarters.
  • Cinctive Capital Management's Transmedics position peaked at $2.48M in Q2 2022.
  • 178 funds tracked by Wall St. Rank held Transmedics as of Q3 2022.

Based on Cinctive Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.